Clinical trial
A Trial of the Efficacy and Safety of Sirolimus(Rapamycin)Therapy for Renal Angiomyolipmoas in Patients With Tuberous Sclerosis Complex and Sporadic Lymphangioleiomyomatosis
NCT00490789 is registered in ClinicalTrials.gov with Cardiff University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Trial of the Efficacy and Safety of Sirolimus(Rapamycin)Therapy for Renal Angiomyolipmoas in Patients With Tuberous Sclerosis Complex and Sporadic Lymphangioleiomyomatosis
- Lead sponsor
- Cardiff University
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- October 31, 2005
- Completion date
- September 30, 2009
- Enrollment
- 14 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.